Tong L, Qian C, Massariol M J, Déziel R, Yoakim C, Lagacé L
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, USA.
Nat Struct Biol. 1998 Sep;5(9):819-26. doi: 10.1038/1860.
Human cytomegalovirus (HCMV) protease belongs to a new class of serine proteases, with a unique polypeptide backbone fold. The crystal structure of the protease in complex with a peptidomimetic inhibitor (based on the natural substrates and covering the P4 to P1' positions) has been determined at 2.7 A resolution. The inhibitor is bound in an extended conformation, forming an anti-parallel beta-sheet with the protease. The P3 and P1 side chains are less accessible to solvent, whereas the P4 and P2 side chains are more exposed. The inhibitor binding mode shows significant similarity to those observed for peptidomimetic inhibitors or substrates of other classes of serine proteases (chymotrypsin and subtilisin). HCMV protease therefore represents example of convergent evolution. In addition, large conformational differences relative to the structure of the free enzyme are observed, which may be important for inhibitor binding.
人巨细胞病毒(HCMV)蛋白酶属于一类新型丝氨酸蛋白酶,具有独特的多肽主链折叠结构。已在2.7埃分辨率下测定了该蛋白酶与一种拟肽抑制剂(基于天然底物,覆盖P4至P1'位置)复合物的晶体结构。抑制剂以伸展构象结合,与蛋白酶形成反平行β-折叠。P3和P1侧链较难接触到溶剂,而P4和P2侧链则更暴露。抑制剂的结合模式与其他类丝氨酸蛋白酶(胰凝乳蛋白酶和枯草杆菌蛋白酶)的拟肽抑制剂或底物的结合模式有显著相似性。因此,HCMV蛋白酶是趋同进化的一个例子。此外,相对于游离酶的结构观察到了较大的构象差异,这可能对抑制剂结合很重要。